Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of scutellaria baicalensis (Chinese name: 黄芩, Huang Qin) and coptis chinensis (Chinese name: 黄连, Huang Lian) is a traditional Chinese herbal medicine pairing widely used for the treatment of various heat-related diseases. This herbal duo is known for its anti-inflammatory, antimicrobial, and hepatoprotective properties. The main active constituents include baicalin from scutellaria baicalensis and berberine from coptis chinensis. These compounds exhibit synergistic effects in modulating inflammation and microbial growth. The combination has been studied for its ability to alleviate acute alcoholic liver injury and other inflammatory conditions by enhancing the bioavailability of active ingredients through specific chemical interactions within the decoction[2][4][1]. Mechanistically, these herbs act on multiple biological targets including inflammatory pathways and microbial agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on scutellaria baicalensis + coptis chinensis.